麻豆传媒

Our 麻豆传媒 on 麻豆传媒

Leading Cancer Clinician, Researcher Dr. Jenny Chang to Lead Houston Methodist Academic Institute

Esteemed cancer clinician-scientist Jenny Chang, M.D., MBBChir, MHCM, has been chosen to lead the Houston Methodist Academic Institute. She will serve as executive vice president, president and CEO, and chief academic officer.
13-Jan-2025 10:15 AM EST Add to Favorites

Houston Methodist Scientists Make Surprising Discovery Pinpointing When Good Cholesterol Becomes Harmful

Houston Methodist researchers have discovered that certain components of so-called 鈥済ood鈥 cholesterol -- high-density lipoproteins (HDL) 鈥 may be associated with an increased prevalence of cardiovascular disease.
18-Dec-2024 10:40 PM EST Add to Favorites

麻豆传媒: 6747542733cfb_HumanConnection-baskin-websize.jpg

Patient Returns to Houston Methodist 20 Years After Lifesaving Surgery

More than two decades ago, Mitra Kamali, 4 1/2 months pregnant with twins at age 45, was having lunch with her husband in Houston when out of nowhere she suffered a major seizure.
27-Nov-2024 12:10 PM EST Add to Favorites

Houston Methodist Researchers Shed Light on Increased Rates of Severe Human Infections Caused by Streptococcus Subspecies

A concerning increase in global rates of severe invasive infections becoming resistant to key antibiotics has a team of infectious disease researchers at the Houston Methodist Research Institute studying a recently emerged strain of bacteria called...
1-Nov-2024 4:00 PM EDT Add to Favorites

Houston Methodist Part of National Consortium to Develop Vaccine Against Herpesviruses

Houston Methodist researchers will be part of a national consortium funded by an up to $49 million award from the U.S. Government鈥檚 Advanced Research Projects Agency for Health (ARPA-H) to develop a vaccine against two of the most common and...
3-Oct-2024 7:05 PM EDT Add to Favorites

New Addition to Standard-of-Care Treatments for Non-Small-Cell Lung Cancer Patients Has Potential to Increase Progression-Free Survival

Houston Methodist researchers have developed an advanced mathematical model that predicts how novel treatment combinations could significantly extend progression-free survival for patients with non-small-cell lung cancer (NSCLC), the most common...
3-Oct-2024 7:05 PM EDT Add to Favorites

Houston Methodist Prepares for Next Pandemic as Part of National NIH-Funded Consortium

The question isn鈥檛 if, but when, the next pandemic will hit. Research and observation have identified strong potential for the next pandemic-causing virus to come from one or more of five different virus families.
3-Oct-2024 7:05 PM EDT Add to Favorites

麻豆传媒: gutmicrobiomeslide-web-size.ashx?mw=1382&hash=7D2FD08137CF7FCFD8BD3433DC214D3D

Houston Methodist and Rice University team up to track gut-brain connection

For the next two years, 120 Division I Rice University athletes will be part of a concussion study with Houston Methodist researchers to identify reliable and novel concussion biomarkers in their gut microbiomes in ways that standard brain imaging...
18-Sep-2024 4:05 PM EDT Add to Favorites


See All News

About

U.S. 麻豆传媒 & World Report has named Houston Methodist Hospital the No. 1 hospital in Texas and among the top 20 hospitals in the nation. Houston Methodist's reputation for outstanding care, treatments and research attracts patients from Texas, the nation and around the world.

Our teams of surgeons, physicians, researchers and other experts collaborate to solve medicine鈥檚 biggest challenges and turn discoveries into new therapies and treatments. Our drive for innovation is rooted in the legacy created by world-renowned cardiac surgeon Dr. Michael E. DeBakey. He performed the first coronary artery bypass surgery in Texas, and pioneered surgical advances, which have become universal practices.

These days, Houston Methodist not only is well established as a leader in heart and vascular treatments, research and education based on DeBakey鈥檚 achievements and reputation, but also is known for spearheading breakthroughs in organ transplantation, orthopedics, cancer treatment and neurology and neuroscience.

Experts

Twitter

Facebook

close
0.71885